F2G
UK - ManchesterBiotechnology
Focus: F2G is a UK-based biotechnology company focused on antifungal drug development, targeting serious infectious diseases with significant unmet medical need. The company operates as a specialized biotech with a concentrated pipeline in invasive fungal infections.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About F2G
AI assessmentNot HiringNo open roles listed right now. Follow F2G to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
FungiScope - A Global Emerging Fungal Infection Registry
Invasive Fungal DiseaseItraconazole oral solution
HealthyClinical Trials (1)
Help build intelligence for F2G
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.